Novel 5′-Norcarbocyclic Derivatives of Bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine Nucleosides

被引:7
作者
Klimenko, Anna A. [1 ]
Matyugina, Elena S. [1 ]
Logashenko, Evgeniya B. [2 ]
Solyev, Pavel N. [1 ]
Zenkova, Marina A. [2 ]
Kochetkov, Sergey N. [1 ]
Khandazhinskaya, Anastasia L. [1 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, 32 Vavilov St, Moscow 119991, Russia
[2] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, 8 Lavrentiev Ave, Novosibirsk 630090, Russia
基金
俄罗斯基础研究基金会;
关键词
5 '-norcarbocyclic nucleoside analogues; antiproliferative properties; structure-activity relationship; BIOLOGICAL EVALUATION; ANALOGS; INHIBITORS; POTENT; VZV;
D O I
10.3390/molecules23102654
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Here we report the synthesis and biological activity of new 5'-norcarbocyclic derivatives of bicyclic pyrrolo-and furano[2,3-d]pyrimidines with different substituents in the heterocyclic ring. Lead compound 3i, containing 6-pentylphenyl substituent, displays inhibitory activity with respect to a number of tumor cells with a moderate selectivity index value. Compound 3i induces cell death by the apoptosis pathway with the dissipation of mitochondrial potential.
引用
收藏
页数:12
相关论文
共 17 条
[1]   Highly stereoselective synthesis of aristeromycin through dihydroxylation of 4-aryl-L-azido-2-cyclopentenes [J].
Ainai, T ;
Wang, YG ;
Tokoro, Y ;
Kobayashi, Y .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (03) :655-659
[2]   Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents [J].
Aziz, Marwa A. ;
Serya, Rabah A. T. ;
Lasheen, Deena S. ;
Abouzid, Khaled A. M. .
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 2 (01) :1-8
[3]   Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication [J].
Balzarini, J ;
McGuigan, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) :5-9
[4]   Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors [J].
Dincer, Sebla ;
Cetin, Kadir Taylan ;
Onay-Besikci, Arzu ;
Olgen, Sureyya .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2013, 28 (05) :1080-1087
[5]  
Framski G., 2014, P 21 ROUND TABL NUCL
[6]   Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties [J].
Framski, Grzegorz ;
Wawrzyniak, Dariusz ;
Jahnz-Wechmann, Zofia ;
Szymanska-Michalak, Agnieszka ;
Kraszewski, Adam ;
Barciszewski, Jan ;
Boryski, Jerzy ;
Stawinski, Jacek .
ACTA BIOCHIMICA POLONICA, 2016, 63 (04) :765-771
[7]  
Fuertes M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P539
[8]   Cytotoxic nucleoside analogues: Different strategies to improve their clinical efficacy [J].
Galmarini, C. M. ;
Popowycz, F. ;
Joseph, B. .
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (11) :1072-1082
[9]   Bioactive fused heterocycles: Nucleoside analogs with an additional ring [J].
Jahnz-Wechmann, Zofia ;
Framski, Grzegorz ;
Januszczyk, Piotr ;
Boryski, Jerzy .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 97 :388-396
[10]   Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases [J].
Jordheim, Lars Petter ;
Durantel, David ;
Zoulim, Fabien ;
Dumontet, Charles .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (06) :447-464